Reported Side Effects and Safety Concerns From Unlicensed Use Retatrutide causes predominantly gastrointestinal side effects, with additional class-level risks including pancreatitis, gallbladder disease, heart rate elevation, and injection site infections
If you choose to go this route, the most common panels for GLP-1 treatment include these blood markers: A1C (hemoglobin A1C): Measures your average blood sugar over the past 23 months and helps identify prediabetes or diabetes, which may influence medication choice or dose-titration strategy
SIRT1 and energy metabolism
The primary composite endpoint (cardiovascular death or worsening heart failure) was reached in 9,9% of the tirzepatide arm versus 15,3% of the placebo arm (HR 0,62, p=0,026)
During this time, verify your protocol adherence, check protein intake, ensure proper injection technique, and rule out lifestyle factors like stress or sleep changes
We've tried other kinds of drugs